Anaphylaxis in Children and Adolescents

Area of Science:

• Immunology
• Allergy and Immunology
• Clinical Medicine

Background:

• Anaphylaxis is a rapid, severe, and potentially fatal systemic hypersensitivity reaction.
• While often immunoglobulin E (IgE)-mediated, anaphylaxis can also result from IgG or immune complex complement-related reactions triggering mast cell degranulation.
• Common triggers include food allergies and medications.

Purpose of the Study:

• To provide a concise overview of anaphylaxis, including its mechanisms, common causes, clinical presentation, and management.
• To emphasize the critical role of epinephrine in anaphylaxis treatment and the importance of patient education.

Main Methods:

• Review of existing literature on anaphylaxis.
• Analysis of common clinical presentations and etiological factors.
• Discussion of current treatment guidelines and emergency protocols.

Main Results:

• Anaphylaxis involves diverse immunologic pathways leading to mast cell activation.
• Skin/mucous membrane symptoms are most frequent, followed by respiratory and gastrointestinal issues.
• Epinephrine is the primary treatment, necessitating education on autoinjector use.

Conclusions:

• Anaphylaxis requires immediate recognition and management, with epinephrine as the cornerstone of therapy.
• Effective patient and caregiver education on recognizing symptoms and using epinephrine autoinjectors is vital for improving outcomes.
• A clear emergency action plan is essential for individuals at risk of anaphylaxis.